Stocks
Funds
Screener
Sectors
Watchlists

Latest DCF Advisers, LLC Stock Portfolio

DCF Advisers, LLC Performance:
2025 Q4: 16.22%YTD: 47.1%2024: 11.27%

Performance for 2025 Q4 is 16.22%, and YTD is 47.1%, and 2024 is 11.27%.

About DCF Advisers, LLC and 13F Hedge Fund Stock Holdings

On 2026-02-11, the fund reported it's updated stock portfolio. In the 13F Holdings report, DCF Advisers, LLC reported an equity portfolio of $372.8 Millions as of 31 Dec, 2025.

The top stock holdings of DCF Advisers, LLC are MU, GOOG, TEVA. The fund has invested 12.8% of it's portfolio in MICRON TECHNOLOGY INC and 4.8% of portfolio in ALPHABET INC.

The fund managers got completely rid off CORVUS PHARMACEUTICALS INC, EA SERIES TRUST (BOB) and NEXTNAV INC (NN) stocks. They significantly reduced their stock positions in PAYPAL HOLDINGS INC (PYPL), ISHARES SILVER TR (SLV) and ANAPTYSBIO INC (ANAB). DCF Advisers, LLC opened new stock positions in CYBIN INC (CYBN), CORVUS PHARMACEUTICALS INC (CRVS) and ALIBABA GROUP HLDG LTD (BABA). The fund showed a lot of confidence in some stocks as they added substantially to LYFT INC (LYFT), TELADOC HEALTH INC (TDOC) and ARDELYX INC (ARDX).

DCF Advisers, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that DCF Advisers, LLC made a return of 16.22% in the last quarter. In trailing 12 months, it's portfolio return was 47.1%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
cybin inc6,344,310
corvus pharmaceuticals inc5,613,300
alibaba group hldg ltd5,482,090
energy transfer l p4,955,240
uber technologies inc4,494,050
astrazeneca plc4,072,500
home depot inc2,924,850
vertex pharmaceuticals inc2,720,160

New stocks bought by DCF Advisers, LLC

Additions

Ticker% Inc.
lyft inc347
teladoc health inc292
ardelyx inc100
qualcom inc32.26
amgen inc17.39
zoom video communications in11.01
nuveen cr strategies income9.96
amazon com inc9.4

Additions to existing portfolio by DCF Advisers, LLC

Reductions

Ticker% Reduced
paypal holdings inc-54.55
ishares silver tr-27.5
anaptysbio inc-26.56
marvell technology inc-19.71
micron technology inc-18.51
xencor inc-18.45
cisco sys inc-16.67
o-i glass inc-16.18

DCF Advisers, LLC reduced stake in above stock

Sold off

Ticker$ Sold
corvus pharmaceuticals inc-5,663,840
cybin inc-2,172,040
energy transfer l p-5,156,580
immuneering corp-1,029,000
arq inc-801,877
esperion therapeutics inc ne-99,300
structure therapeutics inc-1,799,000
barrick gold corp-1,966,200

DCF Advisers, LLC got rid off the above stocks

Sector Distribution

DCF Advisers, LLC has about 29.1% of it's holdings in Others sector.

Sector%
Others29.1
Technology28
Healthcare26.1
Communication Services6.3
Consumer Cyclical4.7
Financial Services3.7
Energy1.6

Market Cap. Distribution

DCF Advisers, LLC has about 58.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP37.2
UNALLOCATED30.9
MEGA-CAP21
MID-CAP3.7
SMALL-CAP3.6
MICRO-CAP3.2

Stocks belong to which Index?

About 52.6% of the stocks held by DCF Advisers, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
S&P 50048.9
Others47.4
RUSSELL 20003.7
Top 5 Winners (%)%
MU
micron technology inc
64.0 %
TEVA
teva pharmaceutical-sp adr
52.6 %
ANAB
anaptysbio inc
50.6 %
SLV
ishares silver tr
44.9 %
VRDN
viridian therapeutics inc
40.9 %
Top 5 Winners ($)$
MU
micron technology inc
22.0 M
TEVA
teva pharmaceutical-sp adr
4.1 M
GOOG
alphabet inc
4.0 M
LLY
lilly eli & co
2.6 M
REGN
regeneron pharmaceuticals
2.1 M
Top 5 Losers (%)%
ZLAB
zai lab ltd
-47.2 %
ORCL
oracle corp
-30.4 %
biohaven ltd
-23.3 %
spotify technology s a
-16.8 %
evotec ag
-15.2 %
Top 5 Losers ($)$
ORCL
oracle corp
-2.5 M
ZLAB
zai lab ltd
-1.5 M
evotec ag
-0.7 M
biohaven ltd
-0.6 M
ZBH
zimmer biomet holdings inc
-0.3 M

DCF Advisers, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of DCF Advisers, LLC

DCF Advisers, LLC has 75 stocks in it's portfolio. About 37.2% of the portfolio is in top 10 stocks. ORCL proved to be the most loss making stock for the portfolio. MU was the most profitable stock for DCF Advisers, LLC last quarter.

Last Reported on: 11 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions